DK1016867T3 - Fremgangsmåde til immunassay af BNP - Google Patents

Fremgangsmåde til immunassay af BNP

Info

Publication number
DK1016867T3
DK1016867T3 DK98941797T DK98941797T DK1016867T3 DK 1016867 T3 DK1016867 T3 DK 1016867T3 DK 98941797 T DK98941797 T DK 98941797T DK 98941797 T DK98941797 T DK 98941797T DK 1016867 T3 DK1016867 T3 DK 1016867T3
Authority
DK
Denmark
Prior art keywords
bnp
mammalian
immunoassay
gdp
gamma
Prior art date
Application number
DK98941797T
Other languages
English (en)
Inventor
Hiroyuki Shimizu
Kazuaki Endo
Hidehisa Asada
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17152093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1016867(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK1016867T3 publication Critical patent/DK1016867T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DK98941797T 1997-09-11 1998-09-10 Fremgangsmåde til immunassay af BNP DK1016867T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24668497 1997-09-11

Publications (1)

Publication Number Publication Date
DK1016867T3 true DK1016867T3 (da) 2006-05-22

Family

ID=17152093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98941797T DK1016867T3 (da) 1997-09-11 1998-09-10 Fremgangsmåde til immunassay af BNP

Country Status (13)

Country Link
US (1) US6828107B2 (da)
EP (1) EP1016867B1 (da)
JP (1) JP3516655B2 (da)
KR (1) KR100563358B1 (da)
CN (1) CN1161609C (da)
AT (1) ATE315228T1 (da)
AU (1) AU731858B2 (da)
CA (1) CA2304263C (da)
DE (1) DE69833118T2 (da)
DK (1) DK1016867T3 (da)
ES (1) ES2256952T3 (da)
NO (1) NO325020B1 (da)
WO (1) WO1999013331A1 (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP2005522669A (ja) * 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド 卒中および脳損傷の診断マーカーおよびその使用方法
JP3691803B2 (ja) * 2002-03-14 2005-09-07 三洋化成工業株式会社 血液中の心不全マーカー定量方法
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
DK3072978T3 (da) 2002-05-09 2018-09-17 Brigham & Womens Hospital Inc : 1l1rl-1 som kardiovaskulær sygdomsmarkør
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
US7135329B2 (en) * 2002-11-18 2006-11-14 Princeton Biomeditech Corporation Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
US7109023B2 (en) * 2002-11-18 2006-09-19 Princeton Biomeditech Corporation Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
EP1625164B1 (en) * 2003-05-12 2011-07-20 Roche Diagnostics GmbH Method of detecting probnp with a monoclonal antibody binding to the amino acids 42-46
PT1638443E (pt) * 2003-06-20 2011-01-25 Mayo Foundation Isoformas de péptido natriurético cerebral
US20080182299A1 (en) * 2004-01-27 2008-07-31 Compugent Ltd. Novel brain natriuretic peptide variants and methods of use thereof
JP2007525213A (ja) * 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
EP2264463A3 (en) * 2004-03-19 2011-08-10 Biomedica Medizinprodukte GmbH & Co KG Prognostic methods for congestive heart failure
AT500800B1 (de) 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
WO2006031583A2 (en) * 2004-09-09 2006-03-23 Biosite Incorporated Methods and compositions for measuring canine bnp and uses thereof
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
CA2629438C (en) 2005-11-09 2014-02-25 Abbott Laboratories Human bnp immunospecific antibodies
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
AU2007244927B2 (en) 2006-04-24 2012-01-12 Critical Care Diagnostics, Inc. Predicting mortality and detecting severe disease
EP2021796B1 (en) 2006-05-01 2012-02-08 Critical Care Diagnostics, Inc. Diagnosis of cardiovascular disease
CA2660294C (en) * 2006-08-08 2017-08-29 Mayo Foundation For Medical Education And Research Diuretic and natriuretic polypeptides
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
WO2008095052A2 (en) 2007-01-30 2008-08-07 Loma Vista Medical, Inc., Biological navigation device
AT504942B1 (de) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
FI20075251A0 (fi) 2007-04-13 2007-04-13 Hytest Oy Immunomääritys epästabiilien antigeenien määrittämiseksi
JP5570415B2 (ja) * 2007-05-08 2014-08-13 アボット・ラボラトリーズ 他のペプチド型に対する交差反応性の低いヒトｂ型ナトリウム利尿ペプチドアッセイ
US8357656B2 (en) * 2007-09-15 2013-01-22 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-C agonists
WO2009086126A2 (en) * 2007-12-21 2009-07-09 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
PL2269063T3 (pl) 2008-04-18 2014-04-30 Critical Care Diagnostics Inc Rokowanie ryzyka głównych niekorzystnych zdarzeń sercowych
WO2009149108A1 (en) 2008-06-02 2009-12-10 Loma Vista Medical, Inc. Inflatable medical devices
WO2010077654A1 (en) * 2008-12-08 2010-07-08 Biosite Incorporated Combined natriuretic peptide assays
CN101923090A (zh) * 2009-06-10 2010-12-22 中国科学院电子学研究所 固定人体脑钠肽的光学敏感膜的制备方法
US9592119B2 (en) 2010-07-13 2017-03-14 C.R. Bard, Inc. Inflatable medical devices
US8778699B2 (en) 2010-08-04 2014-07-15 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
US10188436B2 (en) 2010-11-09 2019-01-29 Loma Vista Medical, Inc. Inflatable medical devices
AU2012262154B2 (en) 2011-05-31 2016-08-04 Idexx Laboratories, Inc. Detection of degradation products of feline NT-proBNP
CN107090028A (zh) 2011-08-30 2017-08-25 梅约医学教育与研究基金会 利钠多肽
US9611305B2 (en) 2012-01-06 2017-04-04 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
CN104737170A (zh) 2012-08-21 2015-06-24 重症监护诊断股份有限公司 多标记风险分层
CN112710852B (zh) * 2021-03-26 2021-08-03 上海美迪西生物医药股份有限公司 一种gnp多肽的检测试剂盒及检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676114B2 (ja) * 1990-04-16 1997-11-12 塩野義製薬株式会社 ｈＢＮＰを認識するモノクローナル抗体および該抗体を用いるｈＢＮＰの免疫測定法
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds

Also Published As

Publication number Publication date
DE69833118T2 (de) 2006-08-31
EP1016867A4 (en) 2004-11-17
AU9001098A (en) 1999-03-29
NO325020B1 (no) 2008-01-14
KR100563358B1 (ko) 2006-03-22
EP1016867B1 (en) 2006-01-04
NO20001273L (no) 2000-05-10
KR20010023853A (ko) 2001-03-26
US6828107B2 (en) 2004-12-07
DE69833118D1 (de) 2006-03-30
ATE315228T1 (de) 2006-02-15
EP1016867A1 (en) 2000-07-05
CA2304263C (en) 2008-07-29
NO20001273D0 (no) 2000-03-10
CN1161609C (zh) 2004-08-11
AU731858B2 (en) 2001-04-05
US20030157596A1 (en) 2003-08-21
ES2256952T3 (es) 2006-07-16
WO1999013331A1 (en) 1999-03-18
JP3516655B2 (ja) 2004-04-05
CA2304263A1 (en) 1999-03-18
CN1278919A (zh) 2001-01-03

Similar Documents

Publication Publication Date Title
DK1016867T3 (da) Fremgangsmåde til immunassay af BNP
GB0008683D0 (en) Assay using porosity-reduction to inhibit migration
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
ES2151528T3 (es) Composicion de calibrador o control para un ensayo de serologia igm.
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
DE3579841D1 (de) Multisites immunometrisches testverfahren.
EP0227440A3 (en) Immunoassay for creatine kinase mb using bound and soluble antibodies
ES2194139T3 (es) Aumento de la sensibilidad en la determinacion inmunoquimica de un analito.
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
ES2094784T3 (es) Procedimiento para la determinacion de un analito.
ATE153134T1 (de) Immunoassayverfahren unter anwendung photothermischer strahlablenkungsspektroskopie
EP1045248A3 (en) Luminescent labeled immunoassay method and analysis element therefor
DE59606685D1 (de) Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
DE69533904D1 (de) Chemische Modifikation von Antikörpern und Antigenen
DE69021921D1 (de) Monoklonale Antikörper gegen den C-Terminus von ANP.
AU5413086A (en) Determination of luteinisng hormone and monoclonal antibodies thereto
ATE260936T1 (de) 5-hydroxytryptophol (5-htol) derivate, antikörper,immunoassays und detektion von kürzfristigem alkoholkonsum
AU3326989A (en) Immunoassay for the detection of alpha-haloacetamides
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6
KR860007545A (ko) 인체 프로릴 4-히드록시라아제의 정량 방법
CA2110019A1 (en) Immunoassays for determining vitamin b12, and reagents and kits therefor
DK0565903T3 (da) Fremgangsmåde til immunologisk bestemmelse af en eller flere analyter